2,α-Dimethyltryptamine: Difference between revisions
Appearance
Content deleted Content added
Updating {{drugbox}} (no changed fields - added verified revid - updated 'DrugBank_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per [[Wikipedia:WikiProject Chemicals/Chembox validation|Chem/ |
|||
(15 intermediate revisions by 9 users not shown) | |||
Line 1: | Line 1: | ||
{{short description|Chemical compound}} |
|||
{{Drugbox |
|||
{{Infobox drug |
|||
⚫ | |||
| Watchedfields = changed |
|||
⚫ | |||
⚫ | |||
⚫ | |||
| image = 2,a-DMT.svg |
| image = 2,a-DMT.svg |
||
| width = 200 |
| width = 200 |
||
| image2 = 2,alpha-DMT_3d_structure.png |
| image2 = 2,alpha-DMT_3d_structure.png |
||
<!--Clinical data--> |
|||
| width = 200 |
|||
| tradename = |
|||
| CASNo_Ref = {{cascite|correct|CAS}} |
|||
| |
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
<!--Pharmacokinetic data--> |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
<!--Identifiers--> |
|||
| CAS_number = 4966-28-3 |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
<!--Chemical data--> |
|||
⚫ | |||
| C=12 | H=16 | N=2 |
|||
⚫ | |||
⚫ | |||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChI = 1S/C12H16N2/c1-8(13)7-11-9(2)14-12-6-4-3-5-10(11)12/h3-6,8,14H,7,13H2,1-2H3 |
| StdInChI = 1S/C12H16N2/c1-8(13)7-11-9(2)14-12-6-4-3-5-10(11)12/h3-6,8,14H,7,13H2,1-2H3 |
||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChIKey = AXZQFXRPULJFQK-UHFFFAOYSA-N |
| StdInChIKey = AXZQFXRPULJFQK-UHFFFAOYSA-N |
||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| InChI = 1S/C12H16N2/c1-8(13)7-11-9(2)14-12-6-4-3-5-10(11)12/h3-6,8,14H,7,13H2,1-2H3 |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
}} |
}} |
||
'''2, |
'''2,α-Dimethyltryptamine''' ('''2,α-DMT''') is a [[tryptamine]] and a lesser-known [[Psychedelics, dissociatives and deliriants|psychedelic drug]]. It is the 2,α-di[[methyl]] [[analog (chemistry)|analog]] of [[dimethyltryptamine|DMT]]. Its synthesis was first reported in 1965.<ref>{{cite journal | vauthors = Heath-Brown B, Philpott PG |title=Studies in the Indole Series. Part I. Indolylalkylamines |journal=Journal of the Chemical Society |date=1965 |issue=Dec |pages=7165–7178|doi=10.1039/jr9650007165 }}</ref> [[Alexander Shulgin]] lists the dosage as 300-500 [[milligram|mg]], and the duration as 7–10 hours in his book ''[[TiHKAL]]'' (''Tryptamines I Have Known and Loved'').<ref>{{CiteTiHKAL|pages=422|name-list-style = vanc }}</ref> 2,α-DMT causes [[mydriasis]] and [[paresthesia]]. It also produces a calm, [[drunk]]-like feeling. Very little data exists about the pharmacological properties, metabolism, and toxicity of 2,α-DMT. |
||
==References== |
==References== |
||
Line 45: | Line 50: | ||
==External links== |
==External links== |
||
* [http://www.erowid.org/library/books_online/tihkal/tihkal07.shtml 2,a-DMT Entry in ''TIHKAL''] |
* [http://www.erowid.org/library/books_online/tihkal/tihkal07.shtml 2,a-DMT Entry in ''TIHKAL''] |
||
* [http://tihkal.info/read.php?domain=tk&id=7 2,α-DMT Entry in TiHKAL • info] |
* [http://tihkal.info/read.php?domain=tk&id=7 2,α-DMT Entry in TiHKAL • info] |
||
{{ |
{{Tryptamines}} |
||
{{DEFAULTSORT:DMT, 2,alpha-}} |
{{DEFAULTSORT:DMT, 2, alpha-}} |
||
[[Category:Psychedelic tryptamines]] |
[[Category:Psychedelic tryptamines]] |
||
{{Psychoactive-stub}} |
{{Psychoactive-stub}} |